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Background and Purpose—Cerebral small vessel disease is characterized by a wide range of focal and global brain changes. 
We used a magnetic resonance imaging segmentation tool to quantify multiple types of small vessel disease–related brain 
changes and examined their individual and combined predictive value on cognitive and functional abilities.
Methods—Magnetic resonance imaging scans of 560 older individuals from LADIS (Leukoaraiosis and Disability Study) 
were analyzed using automated atlas- and convolutional neural network–based segmentation methods yielding volumetric 
measures of white matter hyperintensities, lacunes, enlarged perivascular spaces, chronic cortical infarcts, and global and 
regional brain atrophy. The subjects were followed up with annual neuropsychological examinations for 3 years and 
evaluation of instrumental activities of daily living for 7 years.
Results—The strongest predictors of cognitive performance and functional outcome over time were the total volumes of white 
matter hyperintensities, gray matter, and hippocampi (P<0.001 for global cognitive function, processing speed, executive 
functions, and memory and P<0.001 for poor functional outcome). Volumes of lacunes, enlarged perivascular spaces, and 
cortical infarcts were significantly associated with part of the outcome measures, but their contribution was weaker. In a 
multivariable linear mixed model, volumes of white matter hyperintensities, lacunes, gray matter, and hippocampi remained 
as independent predictors of cognitive impairment. A combined measure of these markers based on Z scores strongly 
predicted cognitive and functional outcomes (P<0.001) even above the contribution of the individual brain changes.
Conclusions—Global burden of small vessel disease–related brain changes as quantified by an image segmentation tool 
is a powerful predictor of long-term cognitive decline and functional disability. A combined measure of white matter 
hyperintensities, lacunar, gray matter, and hippocampal volumes could be used as an imaging marker associated with 
vascular cognitive impairment.   (Stroke. 2020;51:170-178. DOI: 10.1161/STROKEAHA.119.026170.)
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Cerebral small vessel disease (SVD) is a frequent cause of stroke and the primary subtype of vascular cognitive 
impairment. The neuroimaging features of SVD include small 
subcortical infarcts, lacunes, white matter hyperintensities 
(WMH), enlarged perivascular spaces (EPVS), microbleeds, 
and brain atrophy,1 which have been variably associated with 
cognitive performance.2–7
Recently, SVD has been considered as a dynamic whole 
brain disease because of the diffuse nature, common microvas-
cular pathologies, and varying progression of its lesion types.8 
A multifactorial approach, taking comprehensive imaging data 
into consideration with clinical follow-up, may be optimal in 
characterizing the course of SVD. Visual scoring systems for 
combinations of magnetic resonance imaging (MRI) findings 
have been introduced to represent the total load of SVD9 and ce-
rebrovascular disease.10 These scales are pragmatic but limited 
in sensitivity. Since the accumulating brain changes in SVD 
are on a continuum, it is worthwhile to investigate global lesion 
load with continuous measures rather than ordinal scales.
Computer-generated MRI segmentation has become 
available for different types of SVD changes. Brain volume, 
WMH, and infarcts have received the most attention, while 
fewer methods have been presented to quantify lacunes and 
EPVS. This study aimed to find an optimal combination of the 
major SVD-related brain changes by using MRI quantification 
tools. We examined volumetric data of WMH, lacunes, EPVS, 
chronic cortical infarcts, and global and regional brain volume 
to identify the measures with the strongest associations with 
cognitive decline. A combined continuous measure was con-
structed to represent the global burden of brain changes, and 
its predictive value was validated against long-term cognitive 
and functional outcome.
Methods
The data that support the findings of this study are available from the 
corresponding author on reasonable request.
Participants and Design
The data were drawn from LADIS (Leukoaraiosis and Disability 
Study)—a longitudinal multicenter collaboration investigating the 
role of age-related WMH in functional disability.11 In total, 639 sub-
jects, aged 65 to 84 years, were enrolled at 11 European centers. The 
reasons for referral and the inclusion-exclusion criteria are detailed in 
the online-only Data Supplement. At baseline, the subjects were clas-
sified to have mild-to-severe WMH on MRI according to the modified 
Fazekas scale.11 All subjects were independent or had no more than 
minimal impairment in instrumental activities of daily living (IADL) 
as evaluated with the Lawton IADL scale.12
At baseline (2001–2003), the subjects underwent brain MRI and 
clinical assessments including a standard neurological examination, 
functional status evaluation, and a neuropsychological examination. 
In follow-up, the clinical and neuropsychological assessments were 
repeated annually over 3 years. The number of subjects with clinical 
evaluation was 639 at baseline, 582 at the first, 554 at the second, and 
523 at the third follow-up visit. The number of subjects with neuro-
psychological assessment was 638, 569, 496, and 468, respectively.
A prolonged follow-up ≤7 years (2008–2009) was carried out 
by telephone interviews collecting data from the proxy/informant 
with the IADL scale focusing on activities in the past 3 months. 
Conversion from functional independence into disability was de-
fined as an increase of IADL score from 0 or 1 to ≥2. Of the initial 
639 subjects, 94 subjects had died during follow-up. In total, data of 
outcome in terms of functional disability or death were available for 
633 (99%) subjects.
Ethical approval was given by the local ethics committees of each 
center. Written informed consent was received from all participants.
MRI Acquisition
Brain MRI was administered to the subjects according to the same 
protocol at each center. The sequences included T1-weighted 3-di-
mensional magnetization-prepared rapid acquisition gradient-echo, 
T2-weighted fast-spin echo, and fluid-attenuated inversion recovery 
images as described in the online-only Data Supplement.13–15
Image Analysis
Of the original 639 subjects, 78 cases were excluded from this study 
because of incomplete set of MRI sequences and 1 case because of 
failed multimodal registration in preprocessing. The image analysis 
methods and their validation results are presented in detail in the online-
only Data Supplement. An overview of the image analysis strategy is 
given in Figure 1 and examples of the segmentation results in Figure 2. 
The evaluation included WMH, lacunes, EPVS, and brain atrophy 
based on the STRIVE (Standards for Reporting Vascular Changes on 
Neuroimaging) neuroimaging guidelines.1 Chronic cortical infarcts 
were also taken into consideration as occasional concomitant find-
ings in SVD and potential contributors to clinical outcome. However, 
microbleeds and recent subcortical infarcts were not evaluated because 
of unavailable susceptibility and diffusion-weighted imaging data.
WMH, lacunes, infarcts, and EPVS were segmented using 
U-shaped convolutional neural networks on fluid-attenuated inversion 
recovery and T2 and T1 sequences as outlined in Figure 1. The seg-
mentation was performed using 10-fold cross-validation. The ground 
truth segmentations required for training were generated using manual 
and semiautomatic methods. An automated postprocessing of the con-
volutional neural networks results was performed to remove possible 
erroneous segmentations utilizing spatial information from the multi-
atlas segmentation and intensity information from a probabilistic in-
tensity atlas. In addition, the overlap of the segmentations was checked. 
Volumes of the brain structures were measured from T1 images using 
an automated image quantification tool (Combinostics, Ltd, Finland; 
www.cneuro.com/cmri/), by which the brain is segmented into 133 re-
gions with a multi-atlas method. First, 28 best-matching atlases were 
selected from the original 79 manually segmented atlases (http://www.
neuromorphometrics.com/), and the selected atlases were nonrigidly 
registered with the T1 image. The brain segmentation was generated 
from the 28 atlas segmentations using the expectation-maximization 
algorithm. The present analysis comprised volumes of total brain tis-
sue, cerebral gray matter (GM), white matter, lobar regions, and hip-
pocampi. All volumes were normalized for intracranial volume using 
the method described by Buckner et al.16
Neuropsychological Assessment
The LADIS cognitive test battery included the Mini-Mental State 
Examination, the Vascular Dementia Assessment Scale–Cognitive 
Subscale (VADAS), the Stroop Test, and the Trail Making Test.17 
Mini-Mental State Examination and VADAS total scores were used 
as measures of global cognitive function. Cognitive subdomains of 
processing speed, executive functions, and memory were evaluated 
with psychometrically robust compound scores detailed in the online-
only Data Supplement.
Statistical Analyses
The predictive value of each MRI measure on the 4 cognitive scores 
in 3-year follow-up was investigated individually with linear mixed 
modeling (restricted maximum likelihood estimation, unstructured 
covariance structure) to allow for incomplete data in follow-up. After 
ruling out multicollinearity, the measures with the strongest asso-
ciations with cognitive performance in terms of main effects and 
MRI×time interactions (indicating a change over time) and surviv-
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entered simultaneously in a multivariable linear mixed model. The 
measures with significant independent contributions to cognition 
were then combined as equal components into a single score of global 
SVD-related brain changes by averaging the standardized Z scores of 
each volumetric measure. Finally, the significance of the individual 
and combined MRI measures in predicting poor functional outcome 
was analyzed with Cox proportional hazards models.
All analyses were adjusted for age, sex, years of education, and 
study center. The models with multiple MRI predictors were rerun by 
additionally controlling for hypertension and diabetes mellitus, and 
for incident stroke during follow-up. Since all results remained un-
changed, these analyses were not reported. A log transformation was 
applied for WMH, lacunes, cortical infarcts, and EPVS volumes to 
account for nonnormality of the distributions.
Results
Sample Characteristics
The subjects with complete MRI segmentation data (n=560) 
did not differ from the excluded subjects in age, sex, years 
Figure 1. Flowchart of the image analysis methods (detailed description given in the online-only Data Supplement). 3D indicates 3 dimensional; EPVS, 
enlarged perivascular space; FLAIR, fluid-attenuated inversion recovery; and WMH, white matter hyperintensities.
Figure 2. Examples of the segmentation results for brain structures, white matter hyperintensities (WMH), lacunes, cortical infarcts, and enlarged perivascular 
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of education, WMH Fazekas score, or baseline Mini-Mental 
State Examination score (P>0.05). The characteristics of the 
sample are shown in Table 1.
MRI Segmentation Results
The MRI segmentation results of total and regional lesion vol-
umes and brain structures are shown in Table I in the online-
only Data Supplement and correlations between the main MRI 
predictors in Table II in the online-only Data Supplement.
Individual Associations Between the 
MRI Measures and Cognition
The associations between individual MRI volumes and cog-
nitive scores in 3-year follow-up as investigated with linear 
mixed models are presented in Table 2. After adjustments 
for age, sex, education, and center, all WMH volumes were 
significantly associated with worse overall performance in 
all cognitive scores (main effect) and with steeper rate of de-
cline (interaction with time) in processing speed, executive 
functions, and VADAS total score. Total, periventricular, and 
anterior WMH tended to have slightly stronger relationships 
with cognitive scores compared with the other white matter re-
gions, although the differences between regions were modest.
Total and regional lacunar volumes predicted poorer 
overall performance in processing speed, executive func-
tions and VADAS, and steeper decline in processing speed, 
independently of confounders. However, none of the lacunar 
volumes significantly predicted the memory domain score. 
Anterior volumes had slightly more prominent effects on cog-
nition than those of the posterior regions.
Chronic cortical infarcts had relatively low predictive 
value on cognitive performance. Total and regional infarct 
volumes predicted weakly the overall level and change in pro-
cessing speed and executive functions. Higher infarct volume 
was associated with negative main effect on cognitive perfor-
mance, but there was variability in the estimates of change per 
follow-up year (data not shown), and the relationships did not 
survive correction for multiple comparisons.
Total EPVS volume was significantly associated with 
overall performance and decline in processing speed, as well 
as decline in memory and VADAS total score.
Total and regional brain volumes showed strong associa-
tions with decline in all cognitive scores. Total cerebral GM 
and frontal lobe volumes were the strongest predictors of 
speed and executive functions, whereas hippocampal volume 
most prominently predicted memory and VADAS total score.
Independent Contributions of the 
MRI Measures on Cognition
Based on the above-described relationships with cognitive 
functions (Table 2), total volumes of WMH, lacunes, EPVS, 
cerebral GM, and hippocampi were selected and entered 
together in a linear mixed model adjusted for confound-
ers. Cortical infarcts were left out at this stage because of 
their weak associations with cognitive decline. As shown in 
Table 3, total WMH volume significantly predicted all 4 cog-
nitive scores independently of the other lesion types. Lacunar 
volume independently predicted executive functions. Cerebral 
GM volume was associated with processing speed, whereas 
hippocampal volume with VADAS total score, executive func-
tions, and memory (Table 3). EPVS had no independent con-
tribution to any of the cognitive measures.
Global Score of SVD-Related Brain Changes 
as a Predictor of Cognitive Functions
A quantitative global measure of SVD-related brain changes 
was constructed by taking the mean of the standardized MRI 
measures (Z scores) significant in the multivariable mod-
els above, that is, total volumes of WMH, lacunes, cerebral 
GM, and hippocampi. The scales of GM and hippocampal 
volumes were first inversed so that higher scores reflected 
higher degree of brain changes for all variables. This global 
score proved to have strong and consistent associations with 
Table 1. Characteristics of the Study Sample (n=560)
Age, y; mean (SD) 73.5 (5.1)
Sex, women 303 (54.1%)
Education, mean (SD) 9.7 (3.9)
Hypertension 393 (70.2%)
Diabetes mellitus 83 (14.8%)
MMSE baseline, mean (SD) 27.4 (2.4)
MMSE baseline <24 43/559 (7.7%)
MMSE 3-y follow-up, mean (SD) 26.9 (3.8)
MMSE 3-y follow-up <24 55/416 (13.2%)
Conversion to disability in 7-y follow-up 281/555 (50.6%)
Incident stroke in 7-y follow-up 66/560 (11.8%)
WMH Fazekas score
  Mild 250 (44.6%)
  Moderate 179 (32.0%)
  Severe 131 (23.4%)
No. of lacunes*
  0 299 (53.4%)
  1–3 207 (37.0%)
  ≥4 54 (9.6%)
No. of chronic cortical infarcts*
  0 515 (92.0%)
  1 39 (7.0%)
  ≥2 6 (1.0%)
No. of EPVS*
  0 28 (5.0%)
  1–5 258 (46.1%)
  6–10 126 (22.5%)
  ≥11 148 (26.4%)
EPVS indicates enlarged perivascular spaces; MMSE, Mini-Mental State 
Examination; MRI, magnetic resonance imaging; and WMH, white matter 
hyperintensities.
*Numbers of lacunes, cortical infarcts, and enlarged perivascular spaces 
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Table 2. Individual Predictive Values of Magnetic Resonance Imaging Measures on Cognitive Functions in 3-Year Follow-Up
Processing Speed Executive Functions Memory VADAS Total Score
WMH volume
  Total 64.7 (<0.001) 78.2 (<0.001) 19.4 (<0.001) 66.7 (<0.001)
20.7 (<0.001) 8.2 (<0.001) 2.0 (0.113) 5.4 (0.001)
  Periventricular 63.9 (<0.001) 71.4 (<0.001) 31.0 (<0.001) 74.2 (<0.001)
20.5 (<0.001) 6.9 (<0.001) 3.3 (0.021) 7.1 (<0.001)
  Deep 60.8 (<0.001) 73.3 (<0.001) 13.7 (<0.001) 57.5 (<0.001)
19.1 (<0.001) 8.2 (<0.001) 1.4 (0.248) 4.6 (0.004)
  Subcortical 48.1 (<0.001) 46.7 (<0.001) 10.3 (0.001) 42.3 (<0.001)
17.8 (<0.001) 4.4 (0.005) 1.3 (0.275) 3.9 (0.009)
  Anterior 67.2 (<0.001) 75.7 (<0.001) 16.8 (<0.001) 62.7 (<0.001)
19.2 (<0.001) 7.8 (<0.001) 1.7 (0.164) 5.3 (0.001)
  Posterior 53.9 (<0.001) 71.0 (<0.001) 22.3 (<0.001) 54.8 (<0.001)
20.8 (<0.001) 9.2 (<0.001) 2.3 (0.081) 5.2 (0.002)
  Centrum semiovale 59.1 (<0.001) 55.8 (<0.001) 12.8 (<0.001) 36.8 (<0.001)
20.6 (<0.001) 7.3 (<0.001) 1.4 (0.249) 3.4 (0.019)
Lacunar volume
  Total 23.8 (<0.001) 19.0 (<0.001) 1.3 (0.256) 13.3 (<0.001)
8.0 (<0.001) 1.4 (0.237) 0.4 (0.748) 0.8 (0.474)
  Anterior 22.3 (<0.001) 16.0 (<0.001) 1.1 (0.288) 10.7 (0.001)
7.4 (<0.001) 1.1 (0.360) 0.5 (0.650) 0.8 (0.494)
  Posterior 8.1 (0.005) 9.1 (0.003) 0.3 (0.576) 8.9 (0.003)
6.2 (<0.001) 1.2 (0.316) 0.4 (0.789) 0.9 (0.453)
Chronic cortical infarct volume
  Total 4.1 (0.045) 5.3 (0.022) 0.2 (0.682) 0.8 (0.375)
3.3 (0.020) 2.0 (0.110) 0.5 (0.704) 0.6 (0.616)
  Anterior 0.5 (0.462) 5.0 (0.026) 0.0 (0.968) 1.5 (0.222)
0.5 (0.667) 2.3 (0.077) 0.8 (0.478) 0.1 (0.980)
  Posterior 4.1 (0.042) 4.4 (0.037) 0.3 (0.608) 0.5 (0.487)
3.5 (0.016) 1.6 (0.200) 0.4 (0.757) 0.6 (0.598)
  Right 7.7 (0.006) 8.6 (0.004) 0.1 (0.923) 3.2 (0.073)
5.1 (0.002) 2.8 (0.037) 0.6 (0.620) 0.8 (0.510)
  Left 0.2 (0.689) 0.7 (0.398) 1.7 (0.199) 0.1 (0.745)
0.5 (0.688) 0.7 (0.548) 1.2 (0.309) 1.0 (0.374)
Enlarged perivascular space volume
  Total 4.0 (0.047) 0.4 (0.530) 1.7 (0.191) 1.5 (0.221)
6.6 (<0.001) 1.3 (0.260) 3.9 (0.009) 10.6 (<0.001)
Regional brain volumes
  Total brain tissue 49.9 (<0.001) 74.7 (<0.001) 45.7 (<0.001) 56.7 (<0.001)
19.0 (<0.001) 12.4 (<0.001) 9.0 (<0.001) 4.2 (0.006)
  Cerebral GM 103.5 (<0.001) 99.4 (<0.001) 33.3 (<0.001) 45.7 (<0.001)
35.9 (<0.001) 25.8 (<0.001) 6.3 (<0.001) 4.1 (0.007)
  Cerebral white matter 0.5 (0.485) 1.9 (0.171) 8.4 (0.004) 11.7 (<0.001)
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poorer overall level of performance and steeper rate of decline 
across all cognitive scores, surpassing the effects of the indi-
vidual volumes. In linear mixed models identical to individual 
analyses, the global score significantly predicted processing 
speed (main effect F 120.6, P<0.001; interaction with time 
F 37.3, P<0.001), executive functions (F 148.3, P<0.001; F 
21.5, P<0.001), memory (F 54.4, P<0.001; F 7.4, P<0.001), 
and the VADAS total score (F 101.2, P<0.001; F 5.1, P=0.002, 
respectively).
Associations Between MRI Measures and  
Functional Outcome
Poor functional outcome was defined as subject’s transition 
to disability or death within the prolonged 7-year follow-up 
period. As investigated with individual Cox regression analy-
ses controlling for the confounders, poor outcome was signif-
icantly predicted by total WMH (HR, 4.2 [95% CI, 2.9–5.9]; 
P<0.001), lacunar (HR, 8.1 [95% CI, 3.0–21.7]; P<0.001), 
cerebral GM (HR, 0.990 [95% CI, 0.986–0.993]; P<0.001), 
and hippocampal volumes (HR, 0.57 [95% CI, 0.49–0.67]; 
P<0.001) but not by EPVS or cortical infarct volumes 
(P>0.05). In a multivariable model of the 4 significant MRI 
measures, WMH (HR, 2.6 [95% CI, 1.7–3.8]; P<0.001), la-
cunar (HR, 3.2 [95% CI, 1.1–9.4]; P=0.034), and hippo-
campal volumes (HR, 0.67 [95% CI, 0.55–0.81]; P<0.001) 
remained as independent predictors. Finally, the combined 
score of SVD-related brain changes was significantly related 
to functional outcome independently of the confounders (HR, 
2.7 [95% CI, 2.2–3.3]; P<0.001).
Discussion
Thus far, there has been no agreed procedure for how to assess 
the different types of brain changes related to cerebral SVD. 
In the current study, we leveraged the wealth of information 
provided by convolutional neural networks- and atlas-based 
brain MRI segmentation methods to characterize the diverse 
pathologies of SVD in older individuals. The volumes with 
the highest associations with long-term cognitive and func-
tional outcome were identified, and the core features were 
combined to represent the global burden of SVD-related brain 
changes. The results showed that the combined measure was 
a more powerful predictor of cognitive decline than the indi-
vidual measures alone.
When considered in isolation, total WMH and GM volumes 
had the strongest relationships with both global and domain-
specific cognitive performance over a 3-year follow-up. 
Lacunar volumes were significantly related to global cognitive 
function, processing speed, and executive functions but not 
with memory. Anterior regions had slight predominance over 
posterior regions in predicting cognitive functions possibly re-
flecting a dysfunction of frontal-subcortical networks. Of the 
regional brain volumes, hippocampal volume also proved to 
have strong associations with cognitive scores, most promi-
nently with global cognitive function and memory domain. 
However, EPVS and chronic cortical infarct volumes had 
weaker associations with cognitive decline. In the multivari-
able models of multiple MRI measures, total WMH, lacunar, 
GM, and hippocampal volumes remained as independent pre-
dictors of cognitive functions over a 3-year follow-up.
Table 3. Combined Models for Global Small Vessel Disease Burden: 
Independent Significance of the Magnetic Resonance Imaging Predictors on 







WMH 12.8 (<0.001) 32.1 (<0.001) 7.7 (0.006) 18.4 (<0.001)
Lacunes 0.6 (0.458) 7.5 (0.006) 0.0 (0.877) 2.7 (0.102)
EPVS 0.4 (0.506) 0.5 (0.469) 0.1 (0.749) 0.0 (0.852)
Cerebral GM 6.5 (0.011) 1.8 (0.182) 0.3 (0.560) 2.8 (0.096)
Hippocampi 0.1 (0.794) 4.6 (0.032) 26.0 (<0.001) 14.7 (<0.001)
Linear mixed models F for main effect (P value) adjusted for age, sex, year of 
education, and study center. EPVS indicates enlarged perivascular space; GM, 
gray matter; VADAS, Vascular Dementia Assessment Scale–Cognitive Subscale; 
and WMH, white matter hyperintensities.
  Frontal lobes 101.8 (<0.001) 98.2 (<0.001) 23.1 (<0.001) 40.8 (<0.001)
34.9 (<0.001) 25.0 (<0.001) 5.3 (0.001) 3.4 (0.017)
  Parietal lobes 76.5 (<0.001) 68.8 (<0.001) 27.0 (<0.001) 27.0 (<0.001)
28.9 (<0.001) 18.5 (<0.001) 4.4 (0.004) 4.0 (0.009)
  Occipital lobes 66.3 (<0.001) 49.6 (<0.001) 3.8 (0.053) 14.9 (<0.001)
36.2 (<0.001) 11.2 (<0.001) 0.8 (0.515) 3.0 (0.032)
  Temporal lobes 45.6 (<0.001) 52.1 (<0.001) 42.2 (<0.001) 31.4 (<0.001)
11.1 (<0.001) 15.9 (<0.001) 11.2 (<0.001) 2.5 (0.060)
  Hippocampi 41.8 (<0.001) 72.9 (<0.001) 78.4 (<0.001) 63.7 (<0.001)
15.1 (<0.001) 14.9 (<0.001) 11.6 (<0.001) 3.4 (0.018)
Linear mixed models adjusted for age, sex, years of education, and study center. Upper row in each cell: main effect F (P value 
uncorrected) indicates the association between volume and mean cognitive performance across all 4 evaluations. Lower row in each 
cell: volume×time interaction F (P value) indicates the association with change of cognitive performance during follow-up. P value for 
statistical significance after familywise error correction for multiple comparisons is 0.002. GM indicates gray matter; VADAS, Vascular 
Dementia Assessment Scale-Cognitive Subscale; and WMH, white matter hyperintensities.
Table 2. Continued
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The individual contributions of the MRI segmentation 
volumes are in line with earlier studies using either visual 
scales or volumetric measures. Within the LADIS study, cog-
nitive impairment has been related to WMH Fazekas score14 
and semiautomatic volumetry,4,5 number and location of lacu-
nes,4,15 and visual ratings of global and medial temporal lobe 
atrophy.5 The decisive role of WMH, lacunes, and brain at-
rophy in cognitive decline of SVD has been confirmed by 
several other studies.3,6,18 However, despite being a frequent 
imaging finding in SVD, EPVS have not invariably predicted 
cognitive decline.2,3
The selection of MRI features for the global measure of 
brain changes was based on the significance of associations 
between volumes and multiple longitudinal cognitive and 
functional outcomes. As the relationship of individual vol-
umes varied between different outcomes, the selected com-
ponents were given equal weight in the combined score. 
Importantly, brain atrophy as reflected by reduced global and 
regional GM volumes was considered together with vascular 
lesions. Our earlier study has revealed synergistic interactions 
between atrophy and vascular changes on cognitive decline.5 
In SVD, WMH and lacunes are closely related to GM atrophy 
and whole brain volume.19,20 In particular, hippocampal and 
medial temporal lobe atrophy are associated with SVD and 
contribute to cognitive impairment also in the absence of 
Alzheimer pathology.21,22 Brain atrophy is certainly not re-
lated to pure SVD only, as concomitant neurodegenerative 
processes are promoted by SVD. In our study, the mechanisms 
behind hippocampal atrophy remain unclear because specific 
biomarkers of concomitant early Alzheimer disease were un-
available. More important than to disentangle these processes 
etiologically, however, is their obvious contribution to predict-
ing cognitive decline and disability.
The current study is one of the first to analyze the clin-
ical significance of automated MRI segmentation features 
of multiple types of SVD-related brain changes simultane-
ously. The visual composite score suggested by Staals et al9 
has been found to correlate with general cognitive ability23 
and decline in executive functions,24 but the results have 
not been consistent.25 For the visual SVD score, the differ-
ent lesion types are evaluated using dichotomous ratings. 
Continuous volumetric measures are, therefore, expectedly 
more sensitive in detecting global brain changes. Recently, 
a computer-generated global measure of whole brain atrophy 
and vascular disease has been proposed and shown to have 
a stronger relationship with cognition as compared with 
WMH volume alone and visual total SVD score.26 Another 
study has also reported that a combination of SVD features 
contributed more to cognitive performance after stroke than 
the individual measures.27 These studies have been limited by 
relatively small sample sizes and brief cognitive measures. 
Hippocampal volume has not been included in the measures 
of global SVD burden before.
Among the strengths of our study are the large and well-
characterized sample of subjects, a novel image analysis 
approach achieving high accuracy in lesion quantification, 
and the longitudinal design. We found a close correspondence 
between the estimates of brain changes detected with the pre-
sent segmentation method and those obtained with manual 
delineations. Specifically, WMH volume was highly equiva-
lent to the semiautomatic WMH analysis taken as the ground 
truth.13 Lacunes, cortical infarcts, and EPVS also reached 
good accuracy as compared with expert manual delineations 
(online-only Data Supplement). We applied detailed neuro-
psychological evaluations to yield psychometrically sound 
compound indices for both global cognitive function and spe-
cific domains. The assessment was repeated annually over 3 
years, while the evaluation of functional outcome in terms of 
IADL was extended ≤7 years. The associations were inde-
pendent of age, sex, education, study center, and main vas-
cular risk factors.
As the subjects were recruited in clinical settings based 
on WMH found on brain imaging, the sample represents a 
mixed population of cases with different degrees of SVD, 
but the results cannot be directly generalized to other elderly 
populations. Because of unavailable susceptibility-weighted 
MRI sequences, we could not include cerebral microbleeds 
in our analyses, although they are regarded as part of the typ-
ical SVD neuroimaging features1 and have been identified as 
risk factors for cognitive dysfunction.7 Nor were we able to 
differentiate recent subcortical infarcts or cerebral microin-
farcts. Although the present study provides thus far one of 
the most extensive quantifications of multiple types of im-
aging features, the method is still not all-inclusive and thus 
calls for further research.
The imaging data used in this study were relatively het-
erogeneous multicenter data representing the normal clinical 
variability in image quality. The contrast of some images 
was fairly low, and the slice thickness of the T2 and fluid-
attenuated inversion recovery sequences was 5 mm (T1, 1 
mm). Consequently, the smallest EPVS and lacunes were not 
clearly visible. Both lacunes and EPVS often have similar 
appearance in T1 images, which may cause mix-up of the 
segmentations. As the LADIS sample was recruited based on 
age-related WMH, the number of cases with cortical infarcts 
was relatively small (in total 73 infarcts), and the training set 
for the convolutional neural networks remained restricted. 
Utilization of high-resolution and high-quality imaging data 
and larger training set would improve segmentation accu-
racy. Further studies with advanced imaging technologies 
are required to confirm the predictive value of these lesion 
types on cognitive decline.
Various automated image quantification tools are be-
coming part of clinical practice. Although there is a great 
promise of making image interpretation more objective and 
consistent, users should also understand limitations of such 
tools. Visual inspection is necessary to verify the results so 
that possible errors can be taken into account in interpretation. 
In the present study, normalization for intracranial volume 
was done indirectly based on registrations to a reference tem-
plate, which may introduce bias as compared with normaliza-
tion with actual intracranial volume.
Another limitation of our study is a possible attrition bias 
in follow-up neuropsychological data, because subjects with 
more severe decline are more likely to drop out. Linear mixed 
models were used as the statistical approach to allow for in-
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Conclusions
By a robust MRI segmentation method capable of identifying 
multiple types of imaging features of cerebral SVD and brain 
atrophy, we showed that WMH, lacunar, cerebral GM, and 
hippocampal volumes had the greatest independent predic-
tive value for both cognitive and functional outcome in older 
individuals with ≤7-year follow-up. A combined continuous 
measure of these 4 imaging findings was highly predictive 
of cognitive decline, surpassing the contributions of the indi-
vidual cerebrovascular disease biomarkers. Global quantifica-
tion of SVD-related brain changes provides a comprehensive 
neuroimaging metric associated with vascular cognitive im-
pairment and may be desirable for intervention studies as a 
more valid surrogate than single MRI findings.
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